PE backed ASG Eye hires Morgan Stanley and three other bankers for upcoming IPO

In FY24, ASG reported standalone surgical revenue of ₹285 crore, largely driven by cataract procedures, followed by retina, LASIK, cornea, glaucoma and squint treatments.

Leave a Reply